Home  >  Products  >  DGCR2 (DiGeorge syndrome critical region gene 2) Blocking Peptide (the N terminal of protein) (100ug)
DGCR2 (DiGeorge syndrome critical region gene 2) Blocking Peptide (the N terminal of protein) (100ug)

DGCR2 (DiGeorge syndrome critical region gene 2) Blocking Peptide (the N terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-DGCR2 antibody (Catalogue #: ARP46575_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP46575
Size: 100 ug
Weight: 61kDa
Gene: 9993
Format: Lyophilized powder
Target: DGCR2 is the putative adhesion receptor that could be involved in cell-cell or cell-matrix interactions required for normal cell differentiation and migration.Deletions of the 22q11.2 have been associated with a wide range of developmental defects (notably DiGeorge syndrome, velocardiofacial syndrome, conotruncal anomaly face syndrome and isolated conotruncal cardiac defects) classified under the acronym CATCH 22. The DGCR2 gene encodes a novel putative adhesion receptor protein, which could play a role in neural crest cells migration, a process which has been proposed to be altered in DiGeorge syndrome.
Alternative names: DGS-C; DKFZp686I1730; IDD; KIAA0163; LAN; SEZ-12
See Full Product Listings >